02/14/2025 4:32 PM | Candel Therapeutics (Subject) Northpond Ventures, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 3:30 PM | Barone Francesca (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 3:30 PM | Candel Therapeutics (Issuer) Tak Paul Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 3:30 PM | Candel Therapeutics (Issuer) Tyagarajan Seshu (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 3:30 PM | Candel Therapeutics (Issuer) Nichols William Garrett (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 3:30 PM | Candel Therapeutics (Issuer) Schoch Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2025 5:25 AM | Aguilar Laura K. (Reporting) Aguilar-Cordova Estuardo (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2025 3:09 PM | Candel Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025 9:18 AM | Candel Therapeutics (Subject) FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025 9:03 AM | Candel Therapeutics (Subject) FMR LLC (Filed by)
| Form SCHEDULE 13G | |
01/15/2025 7:30 AM | Candel Therapeutics (Subject) Tak Paul Peter (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for CADL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
01/15/2025 7:30 AM | Candel Therapeutics (Subject) Nichols William Garrett (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025 7:30 AM | Barone Francesca (Reporting) Candel Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025 7:30 AM | Candel Therapeutics (Subject) Schoch Charles (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025 7:30 AM | Candel Therapeutics (Subject) Tyagarajan Seshu (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 7:05 AM | Candel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 3:30 PM | Candel Therapeutics (Issuer) Nichols William Garrett (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 3:30 PM | Candel Therapeutics (Issuer) Tyagarajan Seshu (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 3:30 PM | Candel Therapeutics (Issuer) Tak Paul Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 3:30 PM | Candel Therapeutics (Issuer) Schoch Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 3:30 PM | Barone Francesca (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2025 7:27 AM | Candel Therapeutics (Subject) Schoch Charles (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025 7:27 AM | Barone Francesca (Reporting) Candel Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025 7:28 AM | Candel Therapeutics (Subject) Nichols William Garrett (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025 7:28 AM | Candel Therapeutics (Subject) Tak Paul Peter (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025 7:29 AM | Candel Therapeutics (Subject) Tyagarajan Seshu (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/30/2024 6:37 PM | Aguilar Laura K. (Reporting) Aguilar-Cordova Estuardo (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2024 12:59 PM | Aguilar Laura K. (Reporting) Aguilar-Cordova Estuardo (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 3:11 PM | Candel Therapeutics (Issuer) Manning Paul B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 11:30 AM | Candel Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SC 13G | |
12/13/2024 5:12 PM | Aguilar Laura K. (Reporting) Aguilar-Cordova Estuardo (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2024 4:30 PM | Candel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/13/2024 3:36 PM | Candel Therapeutics (Filer)
| Form 424B5 | |
12/12/2024 3:55 PM | Candel Therapeutics (Filer)
| Form 424B5 | |
12/11/2024 6:45 AM | Candel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2024 5:44 PM | Aguilar Laura K. (Reporting) Aguilar-Cordova Estuardo (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 4:46 PM | Barone Francesca (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 4:47 PM | Candel Therapeutics (Issuer) Nichols William Garrett (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 4:48 PM | Candel Therapeutics (Issuer) Tak Paul Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 4:48 PM | Candel Therapeutics (Issuer) Tyagarajan Seshu (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2024 8:12 AM | Barone Francesca (Reporting) Candel Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad) Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000.
Should you sit on the sideline while this is happening? That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y |
11/29/2024 8:13 AM | Candel Therapeutics (Subject) Nichols William Garrett (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024 8:15 AM | Candel Therapeutics (Subject) Tak Paul Peter (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024 8:17 AM | Candel Therapeutics (Subject) Tyagarajan Seshu (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024 5:24 PM | Aguilar Laura K. (Reporting) Aguilar-Cordova Estuardo (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 2:07 PM | Candel Therapeutics (Issuer) Tak Paul Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 7:30 AM | Candel Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024 7:15 AM | Candel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2024 7:58 PM | Aguilar Laura K. (Reporting) Aguilar-Cordova Estuardo (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2024 5:08 PM | Aguilar Laura K. (Reporting) Aguilar-Cordova Estuardo (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/28/2024 5:41 PM | Aguilar Laura K. (Reporting) Aguilar-Cordova Estuardo (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/28/2024 7:30 AM | Candel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/15/2024 4:59 PM | Aguilar Laura K. (Reporting) Aguilar-Cordova Estuardo (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 5:19 PM | Aguilar Laura K. (Reporting) Aguilar-Cordova Estuardo (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/23/2024 4:16 PM | Aguilar-Cordova Estuardo (Reporting) Candel Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024 4:53 PM | Aguilar-Cordova Estuardo (Reporting) Candel Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024 7:15 AM | Candel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 7:30 AM | Candel Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/19/2024 7:26 AM | Candel Therapeutics (Issuer) Nichols William Garrett (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 7:28 AM | Candel Therapeutics (Issuer) Schoch Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 7:29 AM | Candel Therapeutics (Issuer) Tak Paul Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 7:31 AM | Candel Therapeutics (Issuer) Tyagarajan Seshu (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 7:24 AM | Barone Francesca (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 6:28 AM | Candel Therapeutics (Subject) Nichols William Garrett (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024 6:29 AM | Candel Therapeutics (Subject) Schoch Charles (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024 6:31 AM | Candel Therapeutics (Subject) Tak Paul Peter (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024 6:32 AM | Candel Therapeutics (Subject) Tyagarajan Seshu (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024 6:27 AM | Barone Francesca (Reporting) Candel Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 7:32 AM | Candel Therapeutics (Issuer) Nichols William Garrett (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/15/2024 7:34 AM | Candel Therapeutics (Issuer) Schoch Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/15/2024 7:35 AM | Candel Therapeutics (Issuer) Tak Paul Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/15/2024 7:36 AM | Candel Therapeutics (Issuer) Tyagarajan Seshu (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/15/2024 7:30 AM | Barone Francesca (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 6:33 AM | Barone Francesca (Reporting) Candel Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024 6:35 AM | Candel Therapeutics (Subject) Nichols William Garrett (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024 6:36 AM | Candel Therapeutics (Subject) Schoch Charles (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024 6:37 AM | Candel Therapeutics (Subject) Tak Paul Peter (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024 6:38 AM | Candel Therapeutics (Subject) Tyagarajan Seshu (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024 7:39 AM | Candel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/27/2024 7:40 AM | Candel Therapeutics (Issuer) Nguyen Diem (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 7:41 AM | Candel Therapeutics (Issuer) PAPA JOSEPH C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 7:34 AM | Benz Edward J. JR (Reporting) Candel Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 7:35 AM | Candel Therapeutics (Issuer) Gaeta Renee (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 7:36 AM | Candel Therapeutics (Issuer) Loggia Nicoletta (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 7:37 AM | Candel Therapeutics (Issuer) Manning Paul B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 7:39 AM | Candel Therapeutics (Issuer) Martell Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 7:39 AM | Candel Therapeutics (Issuer) Nabel Gary J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 4:20 PM | Candel Therapeutics (Filer)
| Form ARS | |
05/30/2024 3:30 PM | Candel Therapeutics (Filer)
| Form DEF 14A | |
05/24/2024 6:30 AM | Candel Therapeutics (Filer)
| Form 424B5 | |
05/23/2024 4:05 PM | Candel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad) Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000.
Should you sit on the sideline while this is happening? That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y |
05/14/2024 7:30 AM | Candel Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024 7:15 AM | Candel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2024 7:30 AM | Candel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2024 6:33 AM | Candel Therapeutics (Filer)
| Form 10-K/A | |
04/11/2024 8:00 AM | Candel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/09/2024 7:30 AM | Candel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2024 7:30 AM | Candel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 7:00 AM | Candel Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/28/2024 7:16 AM | Candel Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |